746 — Lee & Man Chemical Co Balance Sheet
0.000.00%
- HK$4.48bn
- HK$4.68bn
- HK$3.95bn
- 91
- 91
- 89
- 100
Annual balance sheet for Lee & Man Chemical Co, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 387 | 325 | 422 | 264 | 291 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 309 | 438 | 293 | 349 | 443 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,780 | 2,146 | 1,709 | 1,513 | 1,387 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4,746 | 5,215 | 4,946 | 5,069 | 5,370 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 6,779 | 7,618 | 7,076 | 7,029 | 7,196 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,174 | 1,339 | 1,134 | 1,172 | 1,146 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2,335 | 2,043 | 1,443 | 1,229 | 1,260 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 4,444 | 5,575 | 5,633 | 5,800 | 5,936 |
| Total Liabilities & Shareholders' Equity | 6,779 | 7,618 | 7,076 | 7,029 | 7,196 |
| Total Common Shares Outstanding |